Generics Bulletin Editor’s Picks For Q1 2023

Highlights Across The Off-Patent Sector From January To March 2023

 
• By Dave Wallace
  
Q1 First Quarter Post It Note
The first quarter of 2023 saw the first US Humira biosimilar launch • Source: Constantin Stanciu / Alamy Stock Photo

More from Biosimilars

More from Products